B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), L M Nadler(Dana-Farber Cancer Institute), John G. Gribben(Queen Mary University of London), Gordon J. Freeman(Dana-Farber Cancer Institute), G S Gray(Dana-Farber Cancer Institute)
Cited by 196
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k